CRA was retained by a large insurance company to assess its new IP management business office and make business process recommendations to transition its IP strategy from development of a defensive patent portfolio to a strategy that supports strategic value creation for the company. Extensive interviews with legal, IP management, executive management, IT, supply chain, research and new product development representatives were used to assess current workflows and processes against industry best practices. Specific process improvements and a detailed roadmap were developed to help align the company’s growing patent portfolio with its long-term business goals.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...